Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Peptide receptor radionuclide therapy with (177)Lu-DOTATATE in advanced bronchial carcinoids: prognostic role of thyroid transcription factor 1 and (18)F-FDG PET.
Ianniello A, Sansovini M, Severi S, Nicolini S, Grana CM, Massri K, Bongiovanni A, Antonuzzo L, Di Iorio V, Sarnelli A, Caroli P, Monti M, Scarpi E, Paganelli G. Ianniello A, et al. Among authors: sansovini m. Eur J Nucl Med Mol Imaging. 2016 Jun;43(6):1040-6. doi: 10.1007/s00259-015-3262-8. Epub 2015 Nov 27. Eur J Nucl Med Mol Imaging. 2016. PMID: 26611427 Clinical Trial.
Radioligand therapies in cancer: mapping the educational landscape in Europe.
Bugani V, Battistelli L, Sansovini M, Monti M, Paganelli G, Gich I, Flotats A, Erba PA, Blay JY, la Fougère C, Van Poppel H, Charalambous A, Herrmann K, Giordano A, Györke T, Deroose C, Matteucci F, Carrió I. Bugani V, et al. Among authors: sansovini m. Eur J Nucl Med Mol Imaging. 2023 Jul;50(9):2692-2698. doi: 10.1007/s00259-023-06217-0. Epub 2023 Apr 14. Eur J Nucl Med Mol Imaging. 2023. PMID: 37058168 Free PMC article.
Peptide receptor radionuclide therapy with (90)Y-DOTATOC in recurrent meningioma.
Bartolomei M, Bodei L, De Cicco C, Grana CM, Cremonesi M, Botteri E, Baio SM, Aricò D, Sansovini M, Paganelli G. Bartolomei M, et al. Among authors: sansovini m. Eur J Nucl Med Mol Imaging. 2009 Sep;36(9):1407-16. doi: 10.1007/s00259-009-1115-z. Epub 2009 Mar 25. Eur J Nucl Med Mol Imaging. 2009. PMID: 19319527 Clinical Trial.
Combined use of 177Lu-DOTATATE and metronomic capecitabine (Lu-X) in FDG-positive gastro-entero-pancreatic neuroendocrine tumors.
Nicolini S, Bodei L, Bongiovanni A, Sansovini M, Grassi I, Ibrahim T, Monti M, Caroli P, Sarnelli A, Diano D, Di Iorio V, Grana CM, Cittanti C, Pieri F, Severi S, Paganelli G. Nicolini S, et al. Among authors: sansovini m. Eur J Nucl Med Mol Imaging. 2021 Sep;48(10):3260-3267. doi: 10.1007/s00259-021-05236-z. Epub 2021 Feb 18. Eur J Nucl Med Mol Imaging. 2021. PMID: 33604690 Free PMC article. Clinical Trial.
40 results